PAM
EW icon

Paradigm Asset Management’s Edwards Lifesciences EW Stock Holding History

Paradigm Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163K Buy
+1,800
New +$151K 0.03% 273
2022
Q4 		– Sell
-3,100
Closed -$256K – 528
2022
Q3 		$256K Sell
3,100
-500
-14% -$48.1K 0.09% 260
2022
Q2 		$342K Buy
+3,600
New +$373K 0.1% 253

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Paradigm Asset Management's EW Position: Q2 2026 in Review

Paradigm Asset Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 1,800 shares worth $163K. The stake represents 0.03% of the portfolio and ranks #273 among its holdings. This is a return to the name: Paradigm Asset Management previously reported a position in EW as recently as Q3 2022.

Paradigm Asset Management first reported a position in EW in Q2 2022 and has held it in 3 quarters since. The position peaked at $342K in Q2 2022. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Paradigm Asset Management held 1,800 shares of Edwards Lifesciences worth $163K as of Q2 2026.
  • Edwards Lifesciences was a new Paradigm Asset Management position in Q2 2026.
  • Edwards Lifesciences made up 0.03% of Paradigm Asset Management's portfolio in Q2 2026, its #273 holding.
  • Paradigm Asset Management first reported a position in Edwards Lifesciences in Q2 2022 and has held it in 3 quarters since.
  • Paradigm Asset Management's Edwards Lifesciences position peaked at $342K in Q2 2022.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Paradigm Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.